CN111358905A - 一种治疗肺炎的中药合剂及其制备方法 - Google Patents
一种治疗肺炎的中药合剂及其制备方法 Download PDFInfo
- Publication number
- CN111358905A CN111358905A CN202010281679.1A CN202010281679A CN111358905A CN 111358905 A CN111358905 A CN 111358905A CN 202010281679 A CN202010281679 A CN 202010281679A CN 111358905 A CN111358905 A CN 111358905A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- radix
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 92
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 206010035664 Pneumonia Diseases 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 31
- 241000596154 Belamcanda Species 0.000 claims abstract description 28
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 28
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 28
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 28
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 26
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 23
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 23
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 23
- 235000011477 liquorice Nutrition 0.000 claims abstract description 23
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 22
- 235000006533 astragalus Nutrition 0.000 claims abstract description 21
- 239000010231 banlangen Substances 0.000 claims abstract description 21
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 18
- 235000003893 Prunus dulcis var amara Nutrition 0.000 claims abstract description 16
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 29
- 235000010234 sodium benzoate Nutrition 0.000 claims description 29
- 239000004299 sodium benzoate Substances 0.000 claims description 29
- 241001180876 Saposhnikovia Species 0.000 claims description 28
- 241001573366 Astragalus membranaceus Species 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 244000018633 Prunus armeniaca Species 0.000 claims description 11
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 240000002943 Elettaria cardamomum Species 0.000 claims description 7
- 241000576429 Forsythia suspensa Species 0.000 claims description 7
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims description 7
- 241001671204 Stemona Species 0.000 claims description 7
- 235000005300 cardamomo Nutrition 0.000 claims description 7
- 241000132012 Atractylodes Species 0.000 claims description 6
- 240000000249 Morus alba Species 0.000 claims description 6
- 235000008708 Morus alba Nutrition 0.000 claims description 6
- 235000006751 Platycodon Nutrition 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 6
- 229930189914 platycodon Natural products 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 241000510654 Bupleurum chinense Species 0.000 claims description 5
- 244000236521 Bupleurum rotundifolium Species 0.000 claims description 5
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 claims description 5
- 241000675108 Citrus tangerina Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 239000001567 elettaria cardamomum seed Substances 0.000 claims description 5
- 238000007865 diluting Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 241000357613 Platycodon Species 0.000 claims 2
- 244000081426 Ranunculus ficaria Species 0.000 claims 2
- 206010011224 Cough Diseases 0.000 abstract description 17
- 208000024891 symptom Diseases 0.000 abstract description 16
- 201000010099 disease Diseases 0.000 abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 15
- 206010037660 Pyrexia Diseases 0.000 abstract description 13
- 230000001717 pathogenic effect Effects 0.000 abstract description 7
- 208000036142 Viral infection Diseases 0.000 abstract description 3
- 244000199697 Amomum kepulaga Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 23
- 238000011282 treatment Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 208000011580 syndromic disease Diseases 0.000 description 13
- 206010068319 Oropharyngeal pain Diseases 0.000 description 11
- 201000007100 Pharyngitis Diseases 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 241000711573 Coronaviridae Species 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 241000721047 Danaus plexippus Species 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 241001530126 Scrophularia Species 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000006083 Hypokinesia Diseases 0.000 description 4
- 208000001528 Coronaviridae Infections Diseases 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 241000202726 Bupleurum Species 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- 206010069767 H1N1 influenza Diseases 0.000 description 2
- 208000004852 Lung Injury Diseases 0.000 description 2
- 206010069363 Traumatic lung injury Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 231100000515 lung injury Toxicity 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 201000010740 swine influenza Diseases 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000951473 Schizonepeta Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000008713 qiang-huo Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 239000008767 xiaochaihu Substances 0.000 description 1
- 239000009792 yinqiao Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗肺炎的中药合剂及其制备方法,包括:金银花60‑150份、连翘40‑100份、柴胡40‑100份、羌活40‑100份、苍术40‑100份、苦杏仁40‑100份、防风40‑100份、法半夏40‑100份、陈皮40‑100份、桔梗40‑100份、黄芪40‑100份、玄参60‑150份、白蔻仁24‑60份、板蓝根60‑150份、桑白皮60‑150份、百部40‑100份、射干40‑100份、薄荷20‑50份、生甘草24‑60份、苯甲酸钠1.5‑3.6份。本发明适用于新冠病毒病早、中期以发热、咽痛、咳嗽为主要症状或其他以湿温病邪挟风致病的患者治疗。
Description
技术领域
本发明涉及中医药技术领域,特别涉及一种治疗肺炎的中药合剂及其制备方法。
背景技术
新型冠状病毒感染所致肺炎起初以发热、乏力、干咳、腹泻等症状为主,少数症状不明显,逐渐出现呼吸困难等,具备人传染人的能力,多数预后良好,少数病情危重,病情变化较快,甚至可致迅速导致死亡。感染者有家族集聚现象,传播较快,西医缺乏针对病原体的有效抗病毒药物,以隔离治疗、抗炎、抗病毒、氧疗及对症支持治疗为主。对轻、中症患者主要依赖于自身免疫抵抗,经过一定时间后可慢慢康复;而重症及危重症患者,抗病毒治疗效果不佳,难度大、周期长,容易导致多器官功能衰竭,预后不良,甚至导致死亡。康复患者可能伴随胸膜炎、肺纤维化、心肌炎等后遗症。因此亟须寻找新的有效的治疗方案及药物。
根据冠状病毒病的特征,该病属中医“疫病”、“温病”、“湿温”范畴。中医药历经数千年积累,对于疫病的防治有着丰厚的文献及实践基础,其中,中医温病学的理论与实践价值对于目前防治新型冠状病毒肺炎仍有重要的现实意义。新冠肺炎起于寒湿之地,早期以发热、咽痛、咳嗽、乏力等为主要表现,传染性强,失治误治有进一步加重的趋势。所以必须抓紧时机,早期治疗、快速隔离,预防疾病向重症、危重症转化。中医药治疗这类温病有较好的效果,早期服用中药可以阻断病情进展,减轻症状,改善预后,尽快治愈疾病。
申请号201410740374.7的专利公开了一种治疗H1N1流感引起的病毒性肺损伤的中药组合物,由以下重量份的原料药制成:岗梅根20-40份,广藿香10-20份,羌活5-15份,柴胡10-20份,红花8-20份,金银花10-20份,防风10-20份,荆芥10-20份,连翘9-20份,苍术5-15份,桃仁8-20份,人工牛黄0.35-1份。本发明所述的中药组合物具有透邪解表,解毒宣肺,化痰祛瘀等作用,可用于治疗H1N1流感引起的病毒性肺损伤。
上述中药组合物有金银花、连翘、柴胡、羌活、苍术,可以实现解表、退热、除湿的功能。但是,对于新型冠状病毒感染所致肺炎,还伴有干咳、咽痛、腹泻症状,上述专利缺少中药所谓的“臣药”,不能很好实现调理肠胃等,以配合“君药”实现更为全面的治疗效果,利于人体体能恢复。也没有能很好实现清泻肺热、润肺止咳、解毒利咽的药物组合搭配。因此,对于目前因新冠病毒感染的肺炎,早、中期以发热、咽痛、咳嗽、咳痰为主要症状,以及其他以湿温病邪挟风致病的患者,上述专利并不能起到全面治疗效果。
发明内容
(一)解决的技术问题
本发明的目的在于提供一种治疗肺炎的中药合剂及其制备方法,以解决现有的治疗肺炎的中药药剂不能全面治疗新冠病毒感染的肺炎的问题。
(二)技术方案
为实现上述治疗肺炎的中药合剂及其制备方法解决现有的治疗肺炎的中药药剂不能全面治疗新冠病毒感染的肺炎的问题,本发明提供如下技术方案:
一种治疗肺炎的中药合剂,包括以下成分:金银花60-150重量份、连翘40-100重量份、柴胡40-100重量份、羌活40-100重量份、苍术40-100重量份、苦杏仁40-100重量份、防风40-100重量份、法半夏40-100重量份、陈皮40-100重量份、桔梗40-100重量份、黄芪40-100重量份、玄参60-150重量份、白蔻仁24-60重量份、板蓝根60-150重量份、桑白皮60-150重量份、百部40-100重量份、射干40-100重量份、薄荷20-50重量份、生甘草24-60重量份;另外,苯甲酸钠1.5-3.6重量份。
优选的,所述中药合剂由以下重量份数的中药原料组成:
金银花70-140重量份、连翘50-90重量份、柴胡50-90重量份、羌活50-90重量份、苍术50-90重量份、苦杏仁50-90重量份、防风50-90重量份、法半夏50-90重量份、陈皮50-90重量份、桔梗50-90重量份、黄芪50-90重量份、玄参70-140重量份、白蔻仁30-50重量份、板蓝根70-140重量份、桑白皮70-140重量份、百部50-90重量份、射干50-90重量份、薄荷30-45重量份、生甘草30-50重量份;另外,苯甲酸钠2-3重量份。
优选的,所述中药合剂由以下重量份数的中药原料组成:
金银花60重量份、连翘40重量份、柴胡40重量份、羌活40重量份、苍术40重量份、苦杏仁40重量份、防风40重量份、法半夏40重量份、陈皮40重量份、桔梗40重量份、黄芪40重量份、玄参60重量份、白蔻仁24重量份、板蓝根60重量份、桑白皮60重量份、百部40重量份、射干40重量份、薄荷20重量份、生甘草24重量份;另外,苯甲酸钠1.5重量份;
金银花140重量份、连翘90重量份、柴胡90重量份、羌活90重量份、苍术90重量份、苦杏仁90重量份、防风90重量份、法半夏90重量份、陈皮90重量份、桔梗90重量份、黄芪90重量份、玄参140重量份、白蔻仁55重量份、板蓝根140重量份、桑白皮140重量份、百部90重量份、射干90重量份、薄荷45重量份、生甘草55重量份;另外,苯甲酸钠3重量份;或者
金银花135重量份、连翘85重量份、柴胡85重量份、羌活85重量份、苍术85重量份、苦杏仁85重量份、防风85重量份、法半夏85重量份、陈皮85重量份、桔梗85重量份、黄芪85重量份、玄参135重量份、白蔻仁50重量份、板蓝根135重量份、桑白皮135重量份、百部85重量份、射干85重量份、薄荷40重量份、生甘草50重量份;另外,苯甲酸钠2.5重量份。
优选的,所述柴胡为北柴胡。
一种治疗肺炎的中药合剂制备方法,包括以下步骤:
步骤1、煎煮,按重量份数称取所述中药合剂的中药原料混合均匀,加水煎煮二次,第一次加10倍量水,浸泡0.5小时,煎煮2小时,第二次加8倍量水,煎煮1.5小时,滤过,合并煎液,静置过夜;
步骤2、浓缩,取步骤1药液的上清液,浓缩,备用;
步骤3、稀释,加入苯甲酸钠,加水搅匀得到稀释液;
步骤4、分装和包装,使用药用玻璃瓶分装所述稀释液,然后高温灭菌,即得到中药合剂;其中,所述中药合剂由以下重量份数的中药原料组成:
金银花60-150重量份、连翘40-100重量份、柴胡40-100重量份、羌活40-100重量份、苍术40-100重量份、苦杏仁40-100重量份、防风40-100重量份、法半夏40-100重量份、陈皮40-100重量份、桔梗40-100重量份、黄芪40-100重量份、玄参60-150重量份、白蔻仁24-60重量份、板蓝根60-150重量份、桑白皮60-150重量份、百部40-100重量份、射干40-100重量份、薄荷20-50重量份、生甘草24-60重量份;另外,苯甲酸钠1.5-3.6重量份;
金银花70-140重量份、连翘50-90重量份、柴胡50-90重量份、羌活50-90重量份、苍术50-90重量份、苦杏仁50-90重量份、防风50-90重量份、法半夏50-90重量份、陈皮50-90重量份、桔梗50-90重量份、黄芪50-90重量份、玄参70-140重量份、白蔻仁30-50重量份、板蓝根70-140重量份、桑白皮70-140重量份、百部50-90重量份、射干50-90重量份、薄荷30-45重量份、生甘草30-50重量份;另外,苯甲酸钠2-3重量份;
金银花60重量份、连翘40重量份、柴胡40重量份、羌活40重量份、苍术40重量份、苦杏仁40重量份、防风40重量份、法半夏40重量份、陈皮40重量份、桔梗40重量份、黄芪40重量份、玄参60重量份、白蔻仁24重量份、板蓝根60重量份、桑白皮60重量份、百部40重量份、射干40重量份、薄荷20重量份、生甘草24重量份;另外,苯甲酸钠1.5重量份;
金银花140重量份、连翘90重量份、柴胡90重量份、羌活90重量份、苍术90重量份、苦杏仁90重量份、防风90重量份、法半夏90重量份、陈皮90重量份、桔梗90重量份、黄芪90重量份、玄参140重量份、白蔻仁55重量份、板蓝根140重量份、桑白皮140重量份、百部90重量份、射干90重量份、薄荷45重量份、生甘草55重量份;另外,苯甲酸钠3重量份;或者
金银花135重量份、连翘85重量份、柴胡85重量份、羌活85重量份、苍术85重量份、苦杏仁85重量份、防风85重量份、法半夏85重量份、陈皮85重量份、桔梗85重量份、黄芪85重量份、玄参135重量份、白蔻仁50重量份、板蓝根135重量份、桑白皮135重量份、百部85重量份、射干85重量份、薄荷40重量份、生甘草50重量份;另外,苯甲酸钠2.5重量份。
优选的,所述高温灭菌温度为120-200℃。
优选的,所述灭菌时间为30-40分钟。
(三)有益效果
与现有技术相比,本发明提供了一种治疗肺炎的中药合剂及其制备方法,具备以下有益效果:本发明的君药组合可以实现解表、退热、除湿的功能。臣药可以助君药解表祛湿,畅利三焦,肃降肺气,清泻肺热,解毒利咽,止咳平喘。佐药能助金银花、连翘疏散风热、辛凉解表,同时能清利咽喉,三药同用,加强利咽解毒之功。使药为甘草,调和诸药。本中药合剂既可以实现解表、退热、除湿,也可以治疗干咳、咽痛、腹泻症状。适用于新冠病毒病早、中期以发热、咽痛、咳嗽为主要症状或其他以湿温病邪挟风致病的患者,也可用于医院一线医务人员及与新冠病毒病患者接触的高危人群的预防。
附图说明
图1为本发明一种治疗肺炎的中药合剂的制备工艺流程图。
具体实施方式
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种治疗肺炎的中药合剂,由以下重量份数的中药原料组成:
金银花60-150重量份、连翘40-100重量份、柴胡40-100重量份、羌活40-100重量份、苍术40-100重量份、苦杏仁40-100重量份、防风40-100重量份、法半夏40-100重量份、陈皮40-100重量份、桔梗40-100重量份、黄芪40-100重量份、玄参60-150重量份、白蔻仁24-60重量份、板蓝根60-150重量份、桑白皮60-150重量份、百部40-100重量份、射干40-100重量份、薄荷20-50重量份、生甘草24-60重量份;另外,苯甲酸钠1.5-3.6重量份。
实施例2
一种治疗肺炎的中药合剂,由以下重量份数的中药原料组成:
金银花70-140重量份、连翘50-90重量份、柴胡50-90重量份、羌活50-90重量份、苍术50-90重量份、苦杏仁50-90重量份、防风50-90重量份、法半夏50-90重量份、陈皮50-90重量份、桔梗50-90重量份、黄芪50-90重量份、玄参70-140重量份、白蔻仁30-50重量份、板蓝根70-140重量份、桑白皮70-140重量份、百部50-90重量份、射干50-90重量份、薄荷30-45重量份、生甘草30-50重量份;另外,苯甲酸钠2-3重量份。
实施例3
一种治疗肺炎的中药合剂,由以下重量份数的中药原料组成:
金银花60重量份、连翘40重量份、柴胡40重量份、羌活40重量份、苍术40重量份、苦杏仁40重量份、防风40重量份、法半夏40重量份、陈皮40重量份、桔梗40重量份、黄芪40重量份、玄参60重量份、白蔻仁24重量份、板蓝根60重量份、桑白皮60重量份、百部40重量份、射干40重量份、薄荷20重量份、生甘草24重量份;另外,苯甲酸钠1.5重量份。
实施例4
一种治疗肺炎的中药合剂,由以下重量份数的中药原料组成:
金银花140重量份、连翘90重量份、柴胡90重量份、羌活90重量份、苍术90重量份、苦杏仁90重量份、防风90重量份、法半夏90重量份、陈皮90重量份、桔梗90重量份、黄芪90重量份、玄参140重量份、白蔻仁55重量份、板蓝根140重量份、桑白皮140重量份、百部90重量份、射干90重量份、薄荷45重量份、生甘草55重量份;另外,苯甲酸钠3重量份。
实施例5
一种治疗肺炎的中药合剂,由以下重量份数的中药原料组成:
金银花135重量份、连翘85重量份、柴胡85重量份、羌活85重量份、苍术85重量份、苦杏仁85重量份、防风85重量份、法半夏85重量份、陈皮85重量份、桔梗85重量份、黄芪85重量份、玄参135重量份、白蔻仁50重量份、板蓝根135重量份、桑白皮135重量份、百部85重量份、射干85重量份、薄荷40重量份、生甘草50重量份;另外,苯甲酸钠2.5重量份。
上述所有实施例的柴胡优选为北柴胡。另外,上述实施例加入苯甲酸钠辅助成型,可一定程度地改善合剂的稳定性、安全性,有利于合剂的分装与储存。
本发明上述实施例提到的各组分具有传统组合物不具备的优点和性能,以下结合各组分的性能及药理进行详细阐述:
本发明的中药合剂处方由银翘散、九味羌活汤、小柴胡汤、止嗽散等多个方剂加减组成,主要功效为辛凉解表、理气祛湿、利咽解毒,适用于发热、咳嗽、气喘、乏力,或纳差、呕恶、腹泻等胃肠道症状。根据处方中各单味药的药效与理化性质的差异,中药合剂采用传统水煎煮方法进行提取,并将其制成合剂。本发明配方功效如下:
君药:金银花、连翘、北柴胡、羌活、苍术为君药。金银花、连翘芳香清解,既能辛凉透表解热,又能芳香辟秽解毒;柴胡辛散解肌退热;羌活辛温芳香,发散风寒湿邪;苍术芳香辟秽、醒脾燥湿、兼能解表。五药组合可以实现解表、退热、除湿的功能。
臣药:苦杏仁、防风、法半夏、陈皮、黄芩、玄参、蔻仁、板蓝根、桑白皮、百部共为臣药。防风辛、微温,祛风解表胜湿,助君药解表祛湿;杏仁、半夏、陈皮、蔻仁共奏理气燥湿化痰,气行湿化、畅利三焦,使痰湿之邪安无定所,同时杏仁能肃降肺气、止咳平喘;黄芩、玄参、板蓝根三药合用,清泻肺热、解毒利咽;桑白皮味甘性寒降,主泻肺平喘;百部润肺止咳。上药为臣,理气祛湿,清热解毒利咽、止咳平喘。
佐药:桔梗、射干、薄荷。桔梗宣肺祛痰利咽;射干苦、寒,解毒利咽,降气消痰;薄荷辛、凉,能助金银花、连翘疏散风热、辛凉解表,同时能清利咽喉。三药同用,加强利咽解毒之功。
使药:甘草为使,调和诸药。
总体功效:辛凉解表、理气祛湿、利咽解毒。适用于新型冠状病毒肺炎感染初期,尤其适用伴见发热、咳嗽、咽痛、舌苔略厚、舌尖红的患者。
实施例1-5的治疗肺炎的中药合剂的制备方法,包括以下步骤:
步骤1、煎煮,按重量份数称取所述中药合剂的中药原料混合均匀,加水煎煮二次,第一次加10倍量水,浸泡0.5小时,煎煮2小时,第二次加8倍量水,煎煮1.5小时,滤过,合并煎液,静置过夜;
步骤2、浓缩,取步骤1药液的上清液,浓缩,备用;
步骤3、稀释,加入苯甲酸钠,加水搅匀得到稀释液;
步骤4、分装和包装,使用药用玻璃瓶分装所述稀释液,然后高温灭菌,即得到中药合剂;其中,高温灭菌温度为120-200℃,灭菌时间为30-40分钟。
按照上述配方和工艺制备的中药合剂在临床实际应用中,应用中药合剂联合常规治疗(根据病情给予营养支持治疗、抗病毒治疗及抗菌药物治疗等)的新型冠状病毒肺炎患者130例作为研究对象。全部患者应用中药合剂平均天数为7天。所有患者符合《新型冠状病毒感染的肺炎诊疗方案(试行第五版)》诊断标准。年龄在18周岁以上,符合新型冠状病毒肺炎诊断标准的轻型和普通型患者,排除重型和危重型患者。予以中药合剂口服,1袋/次,2次/天。分析130例新型冠状病毒肺炎早、中期患者的临床资料,包括主要症状(发热、乏力、咳嗽、食欲减退)治疗后的消失率及其他症状体征消失率等,并分析治疗后的总有效率。
从实际治疗结果分析,上述中药合剂可以明显缩短患者发热天数;减轻患者乏力、咳嗽、咽痛、气喘等症状;能明显改善患者食欲。据不完全统计,治疗的总有效率达85%以上。尽管其对患者肺部CT显示的病灶吸收率和新型冠状病毒肺炎核酸检测转阴率有待后续进一步研究结论证实,但对于改善症状,缓解疾病严重程度、缩短病程具有重要临床意义。
临床应用上述中药合剂联合常规治疗过程中,血常规、肝肾功能等实验室检查均未出现明显加重情况。与治疗前相比,所有患者除原有的呼吸道、消化道症状之外,均未出现新的不适症状或加重体征,提示其临床应用安全性良好。
需要说明的是,在本文中,诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。在没有更多限制的情况下,由语句“包括一个……”限定的要素,并不排除在包括所述要素的过程、方法、物品或者设备中还存在另外的相同要素。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (7)
1.一种治疗肺炎的中药合剂,其特征在于,包括以下成分:金银花60-150重量份、连翘40-100重量份、柴胡40-100重量份、羌活40-100重量份、苍术40-100重量份、苦杏仁40-100重量份、防风40-100重量份、法半夏40-100重量份、陈皮40-100重量份、桔梗40-100重量份、黄芪40-100重量份、玄参60-150重量份、白蔻仁24-60重量份、板蓝根60-150重量份、桑白皮60-150重量份、百部40-100重量份、射干40-100重量份、薄荷20-50重量份、生甘草24-60重量份;另外,苯甲酸钠1.5-3.6重量份。
2.根据权利要求1所述的一种治疗肺炎的中药合剂,其特征在于,所述中药合剂由以下重量份数的中药原料组成:
金银花70-140重量份、连翘50-90重量份、柴胡50-90重量份、羌活50-90重量份、苍术50-90重量份、苦杏仁50-90重量份、防风50-90重量份、法半夏50-90重量份、陈皮50-90重量份、桔梗50-90重量份、黄芪50-90重量份、玄参70-140重量份、白蔻仁30-50重量份、板蓝根70-140重量份、桑白皮70-140重量份、百部50-90重量份、射干50-90重量份、薄荷30-45重量份、生甘草30-50重量份;另外,苯甲酸钠2-3重量份。
3.根据权利要求1所述的一种治疗肺炎的中药合剂,其特征在于,所述中药合剂由以下重量份数的中药原料组成:
金银花60重量份、连翘40重量份、柴胡40重量份、羌活40重量份、苍术40重量份、苦杏仁40重量份、防风40重量份、法半夏40重量份、陈皮40重量份、桔梗40重量份、黄芪40重量份、玄参60重量份、白蔻仁24重量份、板蓝根60重量份、桑白皮60重量份、百部40重量份、射干40重量份、薄荷20重量份、生甘草24重量份;另外,苯甲酸钠1.5重量份;
金银花140重量份、连翘90重量份、柴胡90重量份、羌活90重量份、苍术90重量份、苦杏仁90重量份、防风90重量份、法半夏90重量份、陈皮90重量份、桔梗90重量份、黄芪90重量份、玄参140重量份、白蔻仁55重量份、板蓝根140重量份、桑白皮140重量份、百部90重量份、射干90重量份、薄荷45重量份、生甘草55重量份;另外,苯甲酸钠3重量份;或者
金银花135重量份、连翘85重量份、柴胡85重量份、羌活85重量份、苍术85重量份、苦杏仁85重量份、防风85重量份、法半夏85重量份、陈皮85重量份、桔梗85重量份、黄芪85重量份、玄参135重量份、白蔻仁50重量份、板蓝根135重量份、桑白皮135重量份、百部85重量份、射干85重量份、薄荷40重量份、生甘草50重量份;另外,苯甲酸钠2.5重量份。
4.根据权利要求1所述的一种治疗肺炎的中药合剂,其特征在于,所述柴胡为北柴胡。
5.一种治疗肺炎的中药合剂制备方法,其特征在于,包括以下步骤:
步骤1、煎煮,按重量份数称取所述中药合剂的中药原料混合均匀,加水煎煮二次,第一次加10倍量水,浸泡0.5小时,煎煮2小时,第二次加8倍量水,煎煮1.5小时,滤过,合并煎液,静置过夜;
步骤2、浓缩,取步骤1药液的上清液,浓缩,备用;
步骤3、稀释,加入苯甲酸钠,加水搅匀得到稀释液;
步骤4、分装和包装,使用药用玻璃瓶分装所述稀释液,然后高温灭菌,即得到中药合剂;其中,所述中药合剂由以下重量份数的中药原料组成:
金银花60-150重量份、连翘40-100重量份、柴胡40-100重量份、羌活40-100重量份、苍术40-100重量份、苦杏仁40-100重量份、防风40-100重量份、法半夏40-100重量份、陈皮40-100重量份、桔梗40-100重量份、黄芪40-100重量份、玄参60-150重量份、白蔻仁24-60重量份、板蓝根60-150重量份、桑白皮60-150重量份、百部40-100重量份、射干40-100重量份、薄荷20-50重量份、生甘草24-60重量份;另外,苯甲酸钠1.5-3.6重量份;
金银花70-140重量份、连翘50-90重量份、柴胡50-90重量份、羌活50-90重量份、苍术50-90重量份、苦杏仁50-90重量份、防风50-90重量份、法半夏50-90重量份、陈皮50-90重量份、桔梗50-90重量份、黄芪50-90重量份、玄参70-140重量份、白蔻仁30-50重量份、板蓝根70-140重量份、桑白皮70-140重量份、百部50-90重量份、射干50-90重量份、薄荷30-45重量份、生甘草30-50重量份;另外,苯甲酸钠2-3重量份;
金银花60重量份、连翘40重量份、柴胡40重量份、羌活40重量份、苍术40重量份、苦杏仁40重量份、防风40重量份、法半夏40重量份、陈皮40重量份、桔梗40重量份、黄芪40重量份、玄参60重量份、白蔻仁24重量份、板蓝根60重量份、桑白皮60重量份、百部40重量份、射干40重量份、薄荷20重量份、生甘草24重量份;另外,苯甲酸钠1.5重量份;
金银花140重量份、连翘90重量份、柴胡90重量份、羌活90重量份、苍术90重量份、苦杏仁90重量份、防风90重量份、法半夏90重量份、陈皮90重量份、桔梗90重量份、黄芪90重量份、玄参140重量份、白蔻仁55重量份、板蓝根140重量份、桑白皮140重量份、百部90重量份、射干90重量份、薄荷45重量份、生甘草55重量份;另外,苯甲酸钠3重量份;或者
金银花135重量份、连翘85重量份、柴胡85重量份、羌活85重量份、苍术85重量份、苦杏仁85重量份、防风85重量份、法半夏85重量份、陈皮85重量份、桔梗85重量份、黄芪85重量份、玄参135重量份、白蔻仁50重量份、板蓝根135重量份、桑白皮135重量份、百部85重量份、射干85重量份、薄荷40重量份、生甘草50重量份;另外,苯甲酸钠2.5重量份。
6.根据权利要求5所述的一种治疗肺炎的中药合剂制备方法,其特征在于:所述高温灭菌温度为120-200℃。
7.根据权利要求6所述的一种治疗肺炎的中药合剂制备方法,其特征在于:所述灭菌时间为30-40分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010281679.1A CN111358905A (zh) | 2020-04-10 | 2020-04-10 | 一种治疗肺炎的中药合剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010281679.1A CN111358905A (zh) | 2020-04-10 | 2020-04-10 | 一种治疗肺炎的中药合剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111358905A true CN111358905A (zh) | 2020-07-03 |
Family
ID=71199439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010281679.1A Pending CN111358905A (zh) | 2020-04-10 | 2020-04-10 | 一种治疗肺炎的中药合剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111358905A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111951963A (zh) * | 2020-07-30 | 2020-11-17 | 中翰盛泰生物技术股份有限公司 | Hbp在covid-19患者的预后风险预警中的应用 |
CN115998806A (zh) * | 2022-12-30 | 2023-04-25 | 石家庄市中医院 | 一种用于新型冠状病毒感染医学治疗期的中药组合物 |
-
2020
- 2020-04-10 CN CN202010281679.1A patent/CN111358905A/zh active Pending
Non-Patent Citations (2)
Title |
---|
华中科技大学同济医学院附属协和医院: "协和医院中药制剂"金羌宣肺颗粒"获湖北省药监局备案通过", 《HTTP://WWW.WHUH.COM/SEARCH.HTML?MODEL=ARTICLE&KEYWORD=%E9%87%91%E7%BE%8C%E5%AE%A3%E8%82%BA》 * |
风雨同舟296: "武汉协和医院关于"新冠"中医防治方案(第二版)", 《HTTP://WWW.360DOC.COM/CONTENT/20/0213/10/13628199_891671336.SHTML》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111951963A (zh) * | 2020-07-30 | 2020-11-17 | 中翰盛泰生物技术股份有限公司 | Hbp在covid-19患者的预后风险预警中的应用 |
CN115998806A (zh) * | 2022-12-30 | 2023-04-25 | 石家庄市中医院 | 一种用于新型冠状病毒感染医学治疗期的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111265616B (zh) | 一种中药组合物及其在病毒性肺炎防治方面的应用 | |
CN111388582B (zh) | 一种用于新型冠状病毒肺炎的中药组合物及其制剂的应用 | |
CN111569035B (zh) | 一种中药组合物及其在制备治疗新冠肺炎尤其是无症状感染者药物中的应用 | |
CN111388615A (zh) | 一种防治肺炎的中药合剂及其制备方法 | |
CN111671880A (zh) | 用于治疗冠状病毒肺炎发热的中药制剂 | |
CN111249390A (zh) | 一种翘芪复方制剂及其制备方法和用途 | |
CN111773308A (zh) | 防治新冠肺炎“宣肺排毒汤”的中药组合物及制备方法 | |
CN111298049A (zh) | 一种治疗新型冠状病毒肺炎的中药组合物及其应用 | |
CN111110819A (zh) | 治疗或预防新型冠状病毒肺炎、病毒性流感的中药配方 | |
CN111358905A (zh) | 一种治疗肺炎的中药合剂及其制备方法 | |
CN111569010B (zh) | 一种中药组合物及其在制备治疗新冠肺炎的药物中的应用 | |
CN116139237B (zh) | 一种防治新型冠状病毒等所致呼吸道感染的中药组合物及其应用 | |
CN101380411A (zh) | 止咳化痰的中药制剂 | |
CN113350429A (zh) | 一种防治非洲猪瘟疾病的中药组合物及其制备方法与应用 | |
CN104096053A (zh) | 一种治疗小儿肺炎的药物组合物 | |
CN115998824B (zh) | 一种祛湿解毒的中药组合物及其制备方法和应用 | |
CN115300544B (zh) | 一种疏风解表、消肿通窍的中药组合物、贴剂及制备方法 | |
CN105770455A (zh) | 一种治疗支气管哮喘的中药制剂 | |
Xu | TCM and Western Medicine: Diagnosis and Treatment of Novel Coronavirus Pneumonia, A Case Study | |
CN111773302A (zh) | 一种用于治疗重型新冠肺炎的中药组合物及其制备与应用 | |
CN111773336A (zh) | 一种用于治疗普通型新冠肺炎的中药组合物及其制备与应用 | |
CN116549545A (zh) | 一种治疗骨髓炎的中药浸泡方 | |
CN104398578A (zh) | 一种治疗支气管哮喘的黄芪宣肺平喘胶囊 | |
CN117244026A (zh) | 一种荆银清化方和应用 | |
CN117281871A (zh) | 一种治疗呼吸道传染病的中药复方和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200703 |